PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-07-01 pm EDT
52.31 USD   -0.23%
07/01Arbitrator Rules Employer's Two-Dose COVID Vaccine Requirement Not Reasonable (Anymore…)
AQ
07/01Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID
AQ
07/01Pharmaceutical companies still have the upper hand
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on PFIZER, INC.
06/28PFIZER INC : JP Morgan sticks Neutral
MD
06/27PFIZER INC : Barclays reiterates its Neutral rating
MD
05/27PFIZER INC : Berenberg sticks Neutral
MD
05/25PFIZER INC : Goldman Sachs reiterates its Neutral rating
MD
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
05/19PFIZER INC : Berenberg sticks Neutral
MD
05/17PFIZER INC : Barclays remains Neutral
MD
05/04Morgan Stanley Adjusts Pfizer's Price Target to $52 from $55, Keeps Equalweight Rating
MT
05/04Goldman Sachs Adjusts Price Target for Pfizer to $51 From $53, Maintains Neutral Rating
MT
05/04Wells Fargo Adjusts Pfizer's Price Target to $55 from $60, Keeps Overweight Rating
MT
05/04PFIZER INC : Goldman Sachs sticks Neutral
MD
05/04PFIZER INC : Barclays sticks Neutral
MD
05/03PFIZER INC : JP Morgan remains Neutral
MD
04/22Berenberg Bank Adjusts Pfizer's Price Target to $50 From $54, Maintains Hold Rating
MT
04/21PFIZER INC : Berenberg sticks Neutral
MD
04/12Goldman Sachs Adjusts Price Target for Pfizer to $53 From $50, Maintains Neutral Rating
MT
04/05Citigroup Adjusts Pfizer's Price Target to $57 From $46, Maintains Neutral Rating
MT
02/17ANALYST RECOMMENDATIONS : Airbnb, Avis, Pfizer, Roblox, 3M...
02/10Morgan Stanley Adjusts Pfizer Price Target to $55 From $60, Maintains Equal Weight Rati..
MT
02/10Morgan Stanley Adjusts Pfizer's Price Target to $55 from $60, Adjusts Equalweight Ratin..
MT
02/10Mizuho Adjusts Pfizer's Price Target to $55 From $56, Maintains Neutral Rating
MT
02/10ANALYST RECOMMENDATIONS : AIG, American Express, Gartner, Pfizer, Thomson Reuters...
02/09Wells Fargo Adjusts Pfizer's Price Target to $60 From $65, Reiterates Overweight Rating
MT
02/09PFIZER INC : Goldman Sachs reaffirms its Neutral rating
MD
02/09PFIZER INC : Barclays gives a Neutral rating
MD
02/08PFIZER INC : Goldman Sachs reaffirms its Neutral rating
MD
02/08PFIZER INC : JP Morgan gives a Neutral rating
MD
01/14BMO Capital Adjusts Pfizer's Price Target to $76 From $60, Keeps Outperform Rating
MT
01/11PFIZER INC : Barclays reiterates its Neutral rating
MD
01/07Wells Fargo Adjusts Pfizer Price Target to $65 From $60, Maintains Overweight Rating
MT
01/07PFIZER INC : Goldman Sachs sticks Neutral
MD
01/05BofA Securities Upgrades Pfizer to Buy From Neutral, Adjusts Price Target to $70 From $..
MT
2021PFIZER INC : Barclays remains Neutral
MD
2021PFIZER INC : Goldman Sachs gives a Neutral rating
MD
2021PFIZER INC : Goldman Sachs drops its Sell rating
MD
2021Goldman Sachs Analyst Starts Pfizer at Neutral With $51 Price Target
MT
2021Atlantic Securities Adjusts Pfizer PT to $52 From $42, Maintains Neutral Rating
MT
2021SVB Leerink Adjusts Price Target on Pfizer to $56 From $52, Maintains Market Perform Ra..
MT
2021PFIZER INC : Barclays reaffirms its Neutral rating
MD
2021Credit Suisse Downgrades Arena Pharmaceuticals to Neutral from Outperform Following New..
MT
2021RBC Downgrades Arena Pharmaceuticals to Sector Perform From Outperform, Lifts Price Tar..
MT
2021Mizuho Adjusts Pfizer's Price Target to $56 From $44, Maintains Neutral Rating
MT
2021Berenberg Bank Lifts Pfizer's Price Target to $54 From $47, Citing COVID Vaccine Demand..
MT
2021PFIZER INC : JP Morgan gives a Neutral rating
MD
2021UBS Upgrades Pfizer to Buy From Neutral, Adjusts PT to $60 From $52 on Anticipated Paxl..
MT
2021PFIZER INC : Upgraded to Buy by UBS
MD
2021PFIZER INC : Barclays remains Neutral
MD
2021Barclays Adjusts Pfizer's Price Target to $54 From $44, Keeps Equalweight Rating
MT
2021Wells Fargo Starts Pfizer at Overweight With $60 Price Target
MT
2021ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer...
2021PFIZER INC : JP Morgan reiterates its Neutral rating
MD
2021Morgan Stanley Adjusts Pfizer's Price Target to $60 From $50, Maintains Equalweight Rat..
MT
2021JPMorgan Adjusts Pfizer's Price Target to $53 From $42, Reiterates Neutral Rating
MT
2021Truist Securities Adjusts Pfizer's Price Target to $58 From $43, Reiterates Buy Rating
MT
2021BMO Capital Starts Pfizer at Outperform With $60 Price Target
MT
2021PFIZER INC : Barclays reiterates its Neutral rating
MD
2021Independent Research Upgrades Pfizer to Buy from Hold, Adjusts Price Target to $54 from..
MT
2021ANALYST RECOMMENDATIONS : Beyond Meat, HSBC, Pfizer, The Home Depot, Walt Disney...
2021UBS Adjusts Pfizer PT to $52 From $39, Maintains Neutral Rating
MT
2021PFIZER INC : JP Morgan sticks Neutral
MD
2021ANALYST RECOMMENDATIONS : American Water, Chegg, Lyft, Pfizer, Qualcomm...
2021PFIZER INC : Gets a Neutral rating from Barclays
MD
2021SVB Leerink Adjusts Pfizer's Price Target to $48 from $50, Keeps Market Perform Rating
MT
2021PFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $48 From $45, Maintains Equal-We..
MT
2021PFIZER : SVB Leerink Adjusts Pfizer PT to $50 From $49, Maintains Market Perform Rating
MT
2021PFIZER : Cantor Fitzgerald Adjusts Pfizer's Price Target to $61 From $50.24, Reiterates Ov..
MT
2021PFIZER : Berenberg Bank Adjusts Pfizer PT to $47 From $43, Maintains Hold Rating
MT
2021ANALYST RECOMMENDATIONS : Amazon, Barclays, Comcast, Next, Pfizer...
2021PFIZER : Goldman Sachs Adjusts Pfizer's Price Target to $48 From $44, Maintains Neutral Ra..
MT
2021PFIZER : SVB Leerink Adjusts Price Target on Pfizer to $49 From $47, Maintains Market Perf..
MT
2021PFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $45 From $42, Maintains Equal-We..
MT
2021PFIZER INC : Goldman Sachs gives a Neutral rating
MD
2021PFIZER INC : RBC sticks Neutral
MD
2021PFIZER : Price Target From RBC Lifted to $44 From $43 as Firm Raises Vaccine Revenue Forec..
MT
2021ANALYST RECOMMENDATIONS : Anglo American, Pfizer, Rolls-Royce, Nike, Oatly...
1  2  3Next
Upcoming event on PFIZER, INC.